These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28567501)

  • 1. Erratum to: Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
    Eur J Clin Pharmacol; 2017 Jul; 73(7):917. PubMed ID: 28567501
    [No Abstract]   [Full Text] [Related]  

  • 2. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
    Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapyramidal symptoms associated with calcium-channel blockers.
    Daniel JR; Mauro VF
    Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A; Calzetti S
    Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.
    Brücke T; Wöber C; Podreka I; Wöber-Bingöl C; Asenbaum S; Aull S; Wenger S; Ilieva D; Harasko-van der Meer C; Wessely P
    J Cereb Blood Flow Metab; 1995 May; 15(3):513-8. PubMed ID: 7714010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
    Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
    Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the calcium channel blockers cinnarizine and flunarizine on the duration of hexobarbital-induced sleep i rats].
    Marazova KD; Lozeva VG; Belcheva-Beronova A
    Eksp Klin Farmakol; 1993; 56(2):16-8. PubMed ID: 8348027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine.
    Diamond S; Schenbaum H
    Headache; 1983 Jan; 23(1):39-42. PubMed ID: 6826350
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro effects of flunarizine on human lymphocytes.
    Brohée D; Piro P; Kennes B; Nève P
    Cytobios; 1986; 45(182-183):139-46. PubMed ID: 3731875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine.
    Amery WK
    Headache; 1983 Mar; 23(2):70-4. PubMed ID: 6343298
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphonuclear leukocyte as a model of Ca++ and Mg++-dependent cellular activation. Effect of flunarizine.
    Di Perri T; Laghi Pasini F; Pasqui AL; Ceccatelli L; Capecchi PL; Orrico A
    Microcirc Endothelium Lymphatics; 1984 Aug; 1(4):415-29. PubMed ID: 6100790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric histamine content and ulcer formation in rats with ethanol-induced injury. Effects of cinnarizine and flunarizine.
    Lozeva V; Marazova K; Belcheva A
    Agents Actions; 1994 Jun; 41 Spec No():C91-2. PubMed ID: 7976817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].
    Wörz R; Drillisch C
    MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K; Matsuda Y; Kase H; Yamada K
    Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunarizine, a calcium influx blocker, inhibits TRH-but not potassium-stimulated prolactin secretion.
    Merritt JE; Tomlinson S; Brown BL
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):31-5. PubMed ID: 6435368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunarizine in the treatment of vertigo.
    Wouters L; Amery W; Towse G
    J Laryngol Otol; 1983 Aug; 97(8):697-704. PubMed ID: 6350513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R; Correia AS; Bugalho P
    J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.
    Fagbemi O; Kane KA; McDonald FM; Parratt JR; Rothaul AL
    Br J Pharmacol; 1984 Sep; 83(1):299-304. PubMed ID: 6487894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.